Export

EN
FR
Hydroxychloroquine
Essential medicine status
Section:
29. Medicines for diseases of joints 29.2. Disease-modifying anti-rheumatic drugs (DMARDs)
ATC codes: P01BA02
EMLc
Indication
Systemic lupus erythematosus ICD11 code: 4A40.0Z
INN
Hydroxychloroquine
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Oral > Solid: 200 mg (as sulfate)
EML status history
First added in 2011 (TRS 965)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Hydroxychloroquine
DrugBank
Hydroxychloroquine
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended inclusion of hydroxychloroquine on the complementary list of the EML for the treatment of adults with systemic lupus erythematosus, given its beneficial effects in this condition. (Refer to the 2021 recommendation for hydroxychloroquine for the treatment of cutaneous lupus erythematosus).